Category: Health

Nitric oxide and liver health

Nitric oxide and liver health

berghei NK65, on day 17 post-mating. Nitric oxide and liver health large number of study subjects Nitrjc needed for further live of these results. Using the same methodology, our group has confirmed these findings by identifying eNOS expression in isolated primary hepatocytes from WT mice using magnetic-activated cell sorting and immunofluorescence Sheldon et al.

Video

7 Warning Signs of Cirrhosis (End-Stage Liver Disease) - Dr. Berg

Nitric oxide and liver health -

Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis. Toxicol Sci. Tsujimoto, Y. Role of the mitochondrial membrane permeability transition in cell death. Miyoshi, H. NF-kappaB is activated in cholestasis and functions to reduce liver injury.

Lee, J. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology , — Takakuwa, Y. Bile canalicular barrier function and expression of tight-junctional molecules in rat hepatocytes during common bile duct ligation.

Cell Tissue Res. Loke, S. Localisation of CD10 to biliary canaliculi by immunoelectron microscopical examination.

J Clin Pathol. Sugimoto, H. Structural basis of human cytoglobin for ligand binding. J Mol Biol. Clemens, M. Nitric oxide in liver injury. Hepatology 30 , 1—5 Jaeschke, H. Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils.

Toxicol Appl Pharmacol. Kim, Y. Nitric oxide inhibits apoptosis by preventing increases in caspaselike activity via two distinct mechanisms. Dufour, J. Nitric oxide blocks bile canalicular contraction by inhibiting inositol trisphosphate-dependent calcium mobilization.

Balakirev, M. Modulation of the mitochondrial permeability transition by nitric oxide. Eur J Biochem. Schonhoff, C. Nitric oxide-mediated inhibition of taurocholate uptake involves S-nitrosylation of NTCP.

Am J Physiol Gastrointest Liver Physiol. Tipoe, G. Inhibitors of inducible nitric oxide NO synthase are more effective than an NO donor in reducing carbon-tetrachloride induced acute liver injury. Histol Histopathol. CAS Google Scholar. Shafaroodi, H. Cholestasis induces apoptosis in mice cardiac cells: the possible role of nitric oxide and oxidative stress.

Liver Int. Mayoral, P. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation. Clin Sci Lond. Allen, K.

Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Weerachayaphorn, J. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.

J Hepatol. Soylu, A. Antioxidants vitamin E and C attenuate hepatic fibrosis in biliary-obstructed rats. World J Gastroenterol 12 , — Yang, H. Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications.

Mimura, I. Cytoglobin, a novel globin, plays an antifibrotic role in the kidney. Am J Physiol Renal Physiol. Download references. We thank Dr. Keiko Iwaisako for her technical advises and Dr. Kazuo Ikeda for his helpful discussion. TTVT awarded the Japanese Government Scholarship student for PhD course.

LTTT received a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science J NK received a Grant-in-Aid for Scientific Research from JSPS No. Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.

Synthetic Biology Laboratory, Graduate School of Medicine, Osaka City University, Osaka, Japan. You can also search for this author in PubMed Google Scholar. and L.

studied the concept and design, acquired data, analysed and interpreted data, performed all of the experiments, drafted the manuscript and obtained funding. critically revised the manuscript for important intellectual content, and supervised the study.

contributed to the study concept and design, drafted the manuscript, performed critical revisions of the manuscript for important intellectual content, obtained funding and supervised the study. All authors had final approval of the submitted version.

Correspondence to Norifumi Kawada. This work is licensed under a Creative Commons Attribution 4. Reprints and permissions. Van Thuy, T. Sci Rep 7 , Download citation. Received : 20 October Accepted : 29 December Published : 03 February Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. By submitting a comment you agree to abide by our Terms and Community Guidelines.

If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily. Skip to main content Thank you for visiting nature.

nature scientific reports articles article. Download PDF. Subjects Cholestasis Liver fibrosis. Abstract This study clarified the role of Cygb, the fourth globin in mammals originally discovered in rat hepatic stellate cells HSCs , in cholestatic liver disease.

Introduction Cholestatic liver disease is caused by the dysregulated production and excretion of bile from the liver to duodenum, which induces jaundice and the injury of the bile duct and hepatocytes, leading to biliary fibrosis, cirrhosis, and liver failure if persisted 1.

Full size image. Figure 2: Effect of Cygb deficiency on inflammation and cell death in acute BDL. Figure 3: Effect of Cygb deficiency in the expression of bile transporters and CD10 in acute BDL mice. Discussion Loss of Cygb in HSCs aggravates hepatocyte damage under BDL by dysregulation of NO Cygb is expressed in pericytes but not in the epithelial cells of all organs 6.

Loss of Cygb augments inflammation and oxidative stress under BDL In cholestatic liver disease, bile acids are inflammagens that stimulate hepatocytes to produce proinflammatory mediators, promoting the accumulation of neutrophils and other immune cells Methods Animal Studies All mice received humane care according to Guide for the Care and Use of Laboratory Animals, National Institutes of Health.

Bilirubin assay Bilirubin in serum was measured by a spectrophotometric assay by using Bilirubin Assay Kit BioAssay Systems, CA, USA according to the assay protocol.

Hydroxyproline assay Hydroxyproline content of the liver was measured by a spectrophotometric assay by using Hydroxyproline Assay Kit BioVision, CA, USA as previously described MDA assay Oxidative stress was assessed by measuring malondialdehyde MDA , the end products of lipid peroxidation.

Caspase 3 activity assay The caspase 3 activity is one of important hallmarks to assess apoptosis pathway. Quantitative Real-Time PCR The miRNeasy Mini Kit Qiagen, Valencia, CA, USA was used to extract total RNA from cells and liver tissues. Additional Information How to cite this article : Thuy, T.

References Hirschfield, G. Article CAS Google Scholar Aller, M. Article Google Scholar Rust, C. Article CAS Google Scholar Copple, B. Article CAS Google Scholar Kawada, N. Article CAS Google Scholar Nakatani, K. Article CAS Google Scholar Sawai, H.

Article CAS Google Scholar Gardner, A. Article CAS Google Scholar Liu, X. Google Scholar Emara, M. Article Google Scholar Smagghe, B.

Article Google Scholar Liu, X. Article CAS Google Scholar Pacher, P. World J Gastroenterol. PubMed CAS Google Scholar. Langer DA, Shah VH. Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesis. J Hepatol.

Article PubMed CAS Google Scholar. Moriyama A, Masumoto A, Nanri H, Tabaru A, Unoki H, Imoto I, Ikeda M, Otsuki M. Am J Gastroenterol. Arkenau HT, Stichtenoth DO, Frolich JC, Manns MP, Boker KH.

Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.

Z Gastroenterol. Hassan MI, Kassim SK, Ali HS, Sayed el-DA, Khalifa A. Evaluation of nitric oxide NO levels in hepatitis C virus HCV infection: relationship to schistosomiasis and liver cirrhosis among Egyptian patients. Dis Markers. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide?

Sogni P, Moreau R, Gadano A, Lebrec D. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. Elsing C, Harenberg S, Stremmel W, Herrmann T. Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients. Kirkali G, Gezer S, Umur N, Ozcan MA, Tankurt E.

Nitric Oxide in chronic liver disease. Turk J Med Sci. CAS Google Scholar. Pâryu AE, Negrean V, Pleca-Manea1 L, Cosma A, Drãghici A, Uifãlean A, Moldovan R. Nitric Oxide in patients with chronic liver diseases. Rom J Gastroenterol. Google Scholar. Martin PY, Gines P, Schrier RW.

Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. Schweyer S, Mihm S, Radzun HJ, Hartmann H, Fayyazi A.

Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection. Kandemir O, Polat A, Kaya A. Inducible nitric oxide synthase expression in chronic viral hepatitis and its relation with histological severity of disease.

J Viral Hepat. Moussa YI, Plevris JN, Hyes PC. Eur J Gastroentrol Hepatol. Article CAS Google Scholar. de Lucas S, Bartolome J, Amaro MJ, Carreno V. Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-kappa B activation. Antiviral Res. Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J.

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Morales-Ruiz M, Jimenez W. Neovascularization, angiogenesis, vascular remodeling in portal hypertension.

In: Sanyal AJ, Shah VH, editors. Portal hypertension: pathobiology, evaluation and treatment. Totowa NJ: humana press; Duda DG, Fukumura D, Jain RK. Role of eNOS in neovascularization: NO for endothelial progenitor. Trends Mol Med. Bosch J, Garcia-Pagan JC. Complications of cirrhosis.

Portal hypertension. Wattanasirichaigoon S, Gordon FD, Resnick RH. Hyperdynamic circulation in portal hypertension: a comparative model of arterio-venous fistula. Med Hypotheses. Moller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Barak N, Zemel R, Ben-Ari Z, Braun M, Tur-Kaspa R. Nitric oxide metabolites in decompensated liver cirrhosis. Dig Dis Sci. Diagnosis and treatment of portal hypertension. Dig Liver Dis. Article PubMed Google Scholar. Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of oesophageal or gastric varices in patients with advanced liver disease.

Ng FH, Wong SY, Loo CK, Lam KM, Lai CW, Cheng CS. Prediction of oesophagogastric varices in patients with liver cirrhosis. J Gastroenterol Hepatol. Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM, Madichetty H, Kwo PY, Boyer TD. Predictors of large oesophageal varices in patients with cirrhosis.

Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, Mele MR, Testa E, Mansi C, Savarino V, Testa R. Giannini EG, Botta F, Borro P, Dulbecco P, Testa E, Mansi C, Savarino V, Testa R. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol. McKim SE, Gäbele E, Isayama F, Lambert JC, Tucker LM, Wheeler MD, et al.

Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Anavi S, Eisenberg-Bord M, Hahn-Obercyger M, Genin O, Pines M, Tirosh O. The role of iNOS in cholesterol-induced liver fibrosis. Lab Invest. Spruss A, Kanuri G, Uebel K, Bischoff SC, Bergheim I.

Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice. Antioxid Redox Signal. Waki S, Uehara S, Kanbe K, Ono K, Suzuki M, Nariuchi H. The role of T cells in pathogenesis and protective immunity to murine malaria. CAS PubMed PubMed Central Google Scholar.

Heitner JC, Koy C, Kreutzer M, Gerber B, Reimer T, Glocker MO. Differentiation of HELLP patients from healthy pregnant women by proteome analysis—on the way towards a clinical marker set. J Chromatogr B Analyt Technol Biomed Life Sci.

Fisher CD, Lickteig AJ, Augustine LM, Ranger-Moore J, Jackson JP, Ferguson SS, et al. Hepatic cytochrome P enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease. Drug Metab Dispos.

Chiba T, Noji K, Shinozaki S, Suzuki S, Umegaki K, Shimokado K. Diet-induced non-alcoholic fatty liver disease affects expression of major cytochrome P genes in a mouse model. J Pharm Pharmacol.

Na AY, Jo JJ, Kwon OK, Shrestha R, Cho PJ, Kim KM, et al. Investigation of nonalcoholic fatty liver disease-induced drug metabolism by comparative global toxicoproteomics. Toxicol Appl Pharmacol. Anavi S, Tirosh O. iNOS as a metabolic enzyme under stress conditions. Free Radic Biol Med.

Abdelmegeed MA, Jang S, Banerjee A, Hardwick JP, Song BJ. Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury. Waki S, Nakazawa S, Taverne J, Targett GA, Playfair JH. Immunity to an attenuated variant of Plasmodium berghei : role of some non-specific factors.

Yoneto T, Yoshimoto T, Wang CR, Takahama Y, Tsuji M, Waki S, et al. Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical.

McDonald CR, Cahill LS, Gamble JL. Malaria in pregnancy alters l-arginine bioavailability and placental vascular development. Sci Transl Med. Article PubMed PubMed Central Google Scholar. Ngai M, Weckman AM, Erice C, McDonald CR, Cahill LS, Sled JG, et al.

Malaria in pregnancy and adverse birth outcomes: new mechanisms and therapeutic opportunities. Chua CLL, Hasang W, Rogerson SJ, Teo A. Poor birth outcomes in malaria in pregnancy: recent insights into mechanisms and prevention approaches.

Front Immunol. Serghides L, Kim H, Lu Z, Kain DC, Miller C, Francis RC, et al. Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria.

Heiss C, Rodriguez-Mateos A, Kelm M. Central role of eNOS in the maintenance of endothelial homeostasis. Papapetropoulos A, Rudic RD, Sessa WC.

Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res. Jørgensen N, Persson G, Hviid TVF. The tolerogenic function of regulatory T cells in pregnancy and cancer.

Findlay EG, Greig R, Stumhofer JS, Hafalla JC, de Souza JB, Saris CJ, et al. Essential role for IL receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. Jahantigh D, Mousavi M, Forghani F, Javan MR, Movahedinia S, Rezaei M.

Association between maternal circulating IL levels and preeclampsia. Shekhawat P, Bennett MJ, Sadovsky Y, Nelson DM, Rakheja D, Strauss AW. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases.

Am J Physiol Endocrinol Metab. Natarajan SK, Thangaraj KR, Eapen CE, Ramachandran A, Mukhopadhya A, Mathai M, et al. Liver injury in acute fatty liver of pregnancy: possible link to placental mitochondrial dysfunction and oxidative stress.

Download references. The English in this document has been checked by at least two professional editors, both native speakers of English.

This work was supported by a Grant—in—Aid for Scientific Research C from JSPS to M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Department of Infectious Diseases, Kyorin University School of Medicine, 6—20—2 Shinkawa, Mitaka, Tokyo, —, Japan.

Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, Japan. Department of Molecular Pathology, Tokyo Medical University, Tokyo, —, Japan.

Department of Environmental Science, School of Life and Environmental Science, Azabu University, Kanagawa, , Japan. You can also search for this author in PubMed Google Scholar.

MN designed research; MN, TF and SM performed research; MN, TF, JM and FK analyzed data; and MN and FK wrote the paper. All authors read and approved the final manuscript. Correspondence to Mamoru Niikura. The experiments were approved by the Experimental Animal Ethics Committee of Kyorin University School of Medicine, Tokyo, and all experiments were performed in accordance with guidelines and regulations of animal experimentation at Kyorin University.

All contributing authors agreed consent for publication of the manuscript by Malaria Journal. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Comparative proteomic analysis of livers of immunized pregnant mice infected with P. Livers were obtained from unimmunized pregnant mice without infection naïve pregnant mice and unimmunized non-pregnant mice without infection naïve virgin mice , and immunized pregnant and non-pregnant mice infected with P.

Proteins showing one or two peptide spectral matches were excluded. Protein levels were normalized to actin, cytoplasmic 1 accession: P Nitric oxide produced by inducible nitric oxide synthase iNOS is not involved in the development of liver injury during primary infection with lethal malaria parasites.

Unimmunized wild-type WT and iNOS-knockout KO female mice were placed with male WT mice for 1 day. B—E Liver tissue staining with haematoxylin and eosin. Livers were obtained from mice on day 7 post-infection. B Unimmunized non-pregnant WT mice infected with P.

C Unimmunized pregnant WT mice infected with P. D Unimmunized non-pregnant iNOS-KO mice infected with P. E Unimmunized pregnant iNOS-KO mice infected with P.

Comparative proteomic analysis of livers of immunized pregnant inducible nitric oxide synthase-knockout iNOS-KO mice infected with P. Livers were obtained from immunized pregnant mice infected with P. Open Access This article is licensed under a Creative Commons Attribution 4. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material.

If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. Reprints and permissions.

Niikura, M. et al. The association between acute fatty liver disease and nitric oxide during malaria in pregnancy. Malar J 20 , Download citation. Received : 28 September Accepted : 01 December Published : 14 December Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Skip to main content. Search all BMC articles Search. Download PDF. Research Open access Published: 14 December The association between acute fatty liver disease and nitric oxide during malaria in pregnancy Mamoru Niikura ORCID: orcid.

Abstract Background Liver disease is a common feature of malaria in pregnancy, but its pathogenesis remains unclear. Methods To understand the pathogenesis of liver disease during malaria in pregnancy, comparative proteomic analysis of the liver in a mouse model of malaria in pregnancy was performed.

Results Decreased levels of mitochondrial and peroxisomal proteins were observed in the livers of pregnant mice infected with the lethal rodent malaria parasite Plasmodium berghei strain NK Conclusions In this study, a causative role of iNOS in liver disease associated with microvesicular fatty infiltration during malaria in pregnancy was demonstrated.

Background Individuals living in malaria-endemic regions acquire protective immunity against malaria parasites and often show asymptomatic infection. Parasites and infections Lethal P. Histological examination and measurement of parameters of liver injury Livers and blood were obtained from uninfected pregnant and non-pregnant mice, and IM pregnant and non-pregnant mice infected with P.

Comparative proteomic analysis Livers were obtained from uninfected pregnant and non-pregnant mice, and IM pregnant and non-pregnant mice infected with P. Enzyme-linked immunosorbent assay ELISA of cytokines An ELISA for the detection of IFN-γ or IL in plasma was carried out as described previously [ 18 ].

Results Proteomic analysis of the liver of immunized pregnant mice infected with P. Full size image. Table 1 Upregulated proteins in the liver of immunized pregnant mice infected with P. berghei NK65 Full size table.

Table 2 Downregulated proteins in the liver of immunized pregnant mice infected with P. Table 3 Protein levels in the livers of immunized pregnant inducible nitric oxide synthase-knockout iNOS-KO mice infected with P.

Table 4 Upregulated proteins in the livers of immunized pregnant inducible nitric oxide synthase-knockout iNOS-KO mice infected with P. Discussion Pregnant women infected with malaria parasites develop liver disease [ 8 , 9 , 10 ], but its pathogenesis remains unclear.

Conclusions iNOS plays a causative role in the development of liver disease during malaria in pregnancy. Availability of data and materials All data generated or analysed during this study are included in this published article and its additional files.

Abbreviations AFLP: Acute fatty liver of pregnancy ALT: Alanine aminotransferase AST: Aspartic aminotransferase HELLP: Hemolytic anemia; elevated liver enzymes; low platelet count iNOS: Inducible nitric oxide synthase LCHAD: Long-chain 3-hydroxyacyl CoA dehydrogenase NAFLD: Non-alcoholic fatty liver disease PSMs: Peptide spectral matches.

References Menendez C. Article CAS PubMed Google Scholar Nosten F, Rogerson SJ, Beeson JG, McGready R, Mutabingwa TK, Brabin B. Article PubMed Google Scholar Duffy PE.

Article CAS PubMed Google Scholar Rogerson SJ, Boeuf P. Article CAS PubMed Google Scholar Endeshaw Y. CAS PubMed Google Scholar Steketee RW, Nahlen BL, Parise ME, Menendez C. Article CAS PubMed Google Scholar Khan W, Zakai HA, Umm EA. Article CAS PubMed Google Scholar Tournoy J, Dapper I, Spitz B, Meersseman W, Van Wijngaerden E, Lagrou K, et al.

Article PubMed Google Scholar Ducarme G, Thuillier C, Wernet A, Bellier C, Luton D. Article PubMed Google Scholar Castillo Medina NM, Velázquez Fonseca J, Hernández Pacheco JA, Acevedo Tacuba JL.

PubMed Google Scholar Piñeros JG, Tobon-Castaño A, Alvarez G, Portilla C, Blair S. Article PubMed Google Scholar Mineo S, Niikura M, Inoue S, Kuroda M, Kobayashi F. Article CAS PubMed PubMed Central Google Scholar Liu J, Ghaziani TT, Wolf JL.

Article CAS PubMed Google Scholar Ibdah JA. Article CAS PubMed PubMed Central Google Scholar Tran TT, Ahn J, Reau NS. Article CAS PubMed Google Scholar Nelson DB, Byrne JJ, Cunningham FG. Article PubMed Google Scholar Laubach VE, Shesely EG, Smithies O, Sherman PA.

Article CAS PubMed PubMed Central Google Scholar Niikura M, Kamiya S, Kita K, Kobayashi F. Article CAS PubMed Google Scholar Niikura M, Fukutomi T, Fukui K, Inoue SI, Asahi H, Kobayashi F. Article CAS PubMed Google Scholar Niikura M, Inoue SI, Fukutomi T, Yamagishi J, Asahi H, Kobayashi F.

Article CAS PubMed Google Scholar Wang G, Wu WW, Zhang Z, Masilamani S, Shen RF. Article CAS PubMed PubMed Central Google Scholar Käll L, Canterbury JD, Weston J, Noble WS, MacCoss MJ. Article PubMed Google Scholar Niikura M, Fukutomi T, Mineo S, Mitobe J, Kobayashi F.

Article CAS PubMed PubMed Central Google Scholar Miyagami T, Igarshi I, Suzuki M. CAS PubMed Google Scholar Tsai TH, Chen E, Li L, Saha P, Lee HJ, Huang LS, et al. Article CAS PubMed PubMed Central Google Scholar MacMicking JD. Article CAS PubMed PubMed Central Google Scholar McKim SE, Gäbele E, Isayama F, Lambert JC, Tucker LM, Wheeler MD, et al.

Article CAS PubMed Google Scholar Anavi S, Eisenberg-Bord M, Hahn-Obercyger M, Genin O, Pines M, Tirosh O. Article CAS PubMed Google Scholar Spruss A, Kanuri G, Uebel K, Bischoff SC, Bergheim I.

Article CAS PubMed Google Scholar Waki S, Uehara S, Kanbe K, Ono K, Suzuki M, Nariuchi H. CAS PubMed PubMed Central Google Scholar Heitner JC, Koy C, Kreutzer M, Gerber B, Reimer T, Glocker MO.

Article CAS PubMed Google Scholar Fisher CD, Lickteig AJ, Augustine LM, Ranger-Moore J, Jackson JP, Ferguson SS, et al. Article CAS PubMed PubMed Central Google Scholar Chiba T, Noji K, Shinozaki S, Suzuki S, Umegaki K, Shimokado K.

Article CAS PubMed Google Scholar Na AY, Jo JJ, Kwon OK, Shrestha R, Cho PJ, Kim KM, et al. Article CAS PubMed Google Scholar Anavi S, Tirosh O. Article CAS PubMed Google Scholar Abdelmegeed MA, Jang S, Banerjee A, Hardwick JP, Song BJ. Article CAS PubMed PubMed Central Google Scholar Waki S, Nakazawa S, Taverne J, Targett GA, Playfair JH.

Article PubMed Google Scholar Yoneto T, Yoshimoto T, Wang CR, Takahama Y, Tsuji M, Waki S, et al. Article CAS PubMed PubMed Central Google Scholar McDonald CR, Cahill LS, Gamble JL. Article PubMed PubMed Central Google Scholar Ngai M, Weckman AM, Erice C, McDonald CR, Cahill LS, Sled JG, et al.

Article CAS PubMed Google Scholar Chua CLL, Hasang W, Rogerson SJ, Teo A. Article CAS PubMed PubMed Central Google Scholar Serghides L, Kim H, Lu Z, Kain DC, Miller C, Francis RC, et al.

Thank you for visiting nature. Hsalth are using a browser version with limited Nitrid for Nitric oxide and liver health. Healthh obtain the best ans, we recommend you use Muscle definition techniques more up to date browser or turn off compatibility mode in Internet Explorer. In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. This study clarified the role of Cygb, the fourth globin in mammals originally discovered in rat hepatic stellate cells HSCsin cholestatic liver disease. Nitric oxide and liver health

Author: Masho

2 thoughts on “Nitric oxide and liver health

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com